Role of Bariatric Surgery for Reducing Glycated Hemoglobin (Hba1c) in Type 2 Diabetes Mellitus Compared to Current Medicaments Therapy

Firas Farisi Alkaff, Ricardo Adrian Nugraha, Michael Jonatan, Sulistia wati

Abstract views = 596 times | downloads = 619 times


Introduction: Type II is the most common type of Diabetes Mellitus, and one of the most common non-communicable diseases globally. In Indonesia, diabetes contributes to 6% of total deaths. Current medicaments therapy available can only control the disease, not to cure it. Recently, there has been new treatment that has been recommended into standard care for type II Diabetes Mellitus. It was in September 2015 at the second Diabetes Surgery Summit that the introduction of bariatric surgery has been put into standard care for type II Diabetes Mellitus.

Objective: To draw a comparison of the effectiveness between bariatric surgery and current medicaments therapy in reducing HbA1c to achieve remission.

Methods: Literature study was conducted to identify relevant literature showing comparison study between bariatric surgery and medicaments therapy, and comparison study between types of bariatric surgery. 16 Studies are included in this article from 230 studies found.

Results: HbA1c remission in bariatric surgery is significantly higher than medicaments therapy in all studies, ranging from 66.7% vs 0% to 57.1% vs 9.5% during 6-24 months after therapy. Between all types of bariatric surgery, most of the studies shows that Roux-en-Y Gastric Bypass achieves HbA1c remission higher than other types of surgery.

Conclusion: Bariatric surgery is better than current medicaments therapy in achieving HbA1c remission.



Bariatric Surgery; Type 2 Diabetes Mellitus; HbA1c; Remission

Full Text:



NCDAlliance. Diabetes 2016.

WHO. Diabetes Country Profile 2016. 2016.

Tabish SA. Is Diabetes Becoming the Biggest Epidemic of the Twenty‐first Century? . International journal of health sciences. 2007;1(2).

Tjokoprawiro A. Diabetes Mellitus Di Dalam Masyarakat Indonesia. Buletin Penelitian Kesehatan. 1993:42-62.

Ota K. Current status of organ transplants in Asian countries. Transplantation proceedings. 2004;36(9):2535‐8.

Rubino F. Medical research: Time to think differently about diabetes. Nature. 2016;533(7604):459-61.

Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult‐ onset diabetes mellitus. Annals of surgery. 1995;222(3):339‐50.

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2016;12(6):1144-62.

ASMBS. Who is a Candidate for Bariatric Surgery? 2016. Available from:‐is‐a‐candidate‐for‐bariatric‐surgery.

NIH. Gastrointestinal Surgery for Severe Obesity. 1991;9(1).

Lomanto D, Lee WJ, Goel R, Lee JJ, Shabbir A, So JB, et al. Bariatric surgery in Asia in the last 5 years (2005-2009). Obesity surgery. 2012;22(3):502-6.

Stegenga H, Haines A, Jones K, Wilding J, Guideline Development G. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. Bmj. 2014;349:g6608.

Arterburn D, Bogart A, Coleman KJ, Haneuse S, Selby JV, Sherwood NE, et al. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obesity research & clinical practice. 2013;7(4):e258-68.

Heo YS, Park JM, Kim YJ, Kim SM, Park DJ, Lee SK, et al. Bariatric surgery versus conventional therapy in obese Korea patients: a multicenter retrospective cohort study. Journal of the Korean Surgical Society. 2012;83(6):335-42.

Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA surgery. 2015;150(10):931-40.

Ikramuddin S, Billington CJ, Lee WJ, Bantle JP, Thomas AJ, Connett JE, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. The lancet Diabetes & endocrinology. 2015;3(6):413-22.

Parikh M, Chung M, Sheth S, McMacken M, Zahra T, Saunders JK, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Annals of surgery. 2014;260(4):617-22; discussion 22-4.

Halperin F, Ding SA, Simonson DC, Panosian J, Goebel-Fabbri A, Wewalka M, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA surgery. 2014;149(7):716-26.

Courcoulas AP, Goodpaster BH, Eagleton JK, Belle SH, Kalarchian MA, Lang W, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA surgery. 2014;149(7):707-15.

Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240-9.

Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175-82.

Cummings DE, Arterburn DE, Westbrook EO, Kuzma JN, Stewart SD, Chan CP, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59(5):945-53.

Lee SK, Heo Y, Park JM, Kim YJ, Kim SM, Park do J, et al. Roux-en-Y Gastric Bypass vs. Sleeve Gastrectomy vs. Gastric Banding: The First Multicenter Retrospective Comparative Cohort Study in Obese Korean Patients. Yonsei medical journal. 2016;57(4):956-62.

Park JY, Kim YJ. Laparoscopic gastric bypass vs sleeve gastrectomy in obese Korean patients. World journal of gastroenterology. 2015;21(44):12612-9.

Yang J, Wang C, Cao G, Yang W, Yu S, Zhai H, et al. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2). BMC surgery. 2015;15:88.

Huang CK, Garg A, Kuao HC, Chang PC, Hsin MC. Bariatric surgery in old age: a comparative study of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in an Asia centre of excellence. Journal of biomedical research. 2015;29(2):118-24.

Peterli R, Borbely Y, Kern B, Gass M, Peters T, Thurnheer M, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Annals of surgery. 2013;258(5):690-4; discussion 5.

Tang Q, Sun Z, Zhang N, Xu G, Song P, Xu L, et al. Cost-Effectiveness of Bariatric Surgery for Type 2 Diabetes Mellitus: A Randomized Controlled Trial in China. Medicine. 2016;95(20):e3522.

Knop FK, Taylor R. Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care. 2013;36 Suppl 2:S287-91.

Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. American journal of physiology Endocrinology and metabolism. 2005;288(2):E447‐53.

Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. The Journal of clinical endocrinology and metabolism. 2004;89(6):2608-15.

Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Annals of surgery. 2004;239(1):1-11.

Mithieux G. A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition. 2009;25(9):881-4.


  • There are currently no refbacks.

Copyright (c) 2018 Firas Farisi Alkaff, Ricardo Adrian Nugraha, Michael Jonatan, Sulistia wati

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



Creative Commons License

This Journal (E-ISSN:2620-8636) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

View BHSJ Stats